Apt Therapeutics, Inc.

Naperville, IL

UEI
U14VGSZ1X7H8
CAGE
Not on record
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
1701 Quincy Ave #21, Naperville, IL 60540, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Multi-functional anti-thrombotic therapy for coronary microvascular obstruction - principal investigator/program… R44HL169132 National Heart Lung and Blood Institute (NIH) $9,185,716
Immunomodulatory therapy for neuropathic pain - principal investigator/program director (last, first, middle: ridong… R44NS106850 National Institute of Neurological Disorders and Stroke (NIH) $5,327,914

Quick answers

Is Apt Therapeutics, Inc. registered in SAM.gov?

Yes. Apt Therapeutics, Inc.'s SAM.gov registration is active through September 8, 2027.

What is Apt Therapeutics, Inc.'s most recent federal award?

Apt Therapeutics, Inc.'s most recent federal grant award is Multi-functional anti-thrombotic therapy for coronary microvascular obstruction - principal investigator/program… (R44HL169132), from National Heart Lung and Blood Institute (NIH), on May 1, 2023.

On GovTribe

See Apt Therapeutics, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login